LeMaitre Vascular to Present at the UBS Virtual Global Healthcare Conference
LeMaitre Vascular, listed on Nasdaq under the symbol LMAT, will be presented by President David Roberts at the UBS Virtual Global Healthcare Conference on May 20, 2020, at 8:20 AM EDT. The company specializes in developing and marketing devices for peripheral vascular disease, impacting over 200 million people globally. Their extensive product range focuses on disposable and implantable vascular devices tailored for vascular surgeons, enhancing treatment options for patients.
- None.
- None.
BURLINGTON, Mass., May 12, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the UBS Virtual Global Healthcare Conference on Wednesday, May 20, 2020, at 8:20 AM EDT.
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com
Contact: LeMaitre Vascular, Inc. Sandra Millar +1-781-425-1686
FAQ
When is LeMaitre Vascular's presentation at the UBS Virtual Global Healthcare Conference?
What does LeMaitre Vascular specialize in?
How many people are affected by peripheral vascular disease worldwide?
What is the stock symbol for LeMaitre Vascular?
Where can I find more information about LeMaitre Vascular?
